27 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/actinium-pharmaceuticals-announces-atnm-400-a-novel-non-psma-targeting-first-in-class-prostate-cancer-radiotherapy-leveraging-actinium-225-302412945.html
27 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/actinium-pharmaceuticals-provides-business-update-after-presentation-at-trump-mar-a-lago-club-announcing-novel-non-psma-prostate-cancer-radiotherapy-atnm-400-and-outlining-revitalized-clinical-pipeline-with-2025-corporate-objectiv-302413074.html
11 Dec 2024
// BUSINESSWIRE
18 Oct 2024
// BUSINESSWIRE
01 Oct 2024
// BUSINESSWIRE
22 Jul 2024
// BUSINESSWIRE